Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $41.00 USD
Change Today +7.36 / 21.88%
Volume 16.7M
MDCO On Other Exchanges
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Glenn P. Sblendorio MBA

President, Chief Financial Officer, Treasurer and Director,The Medicines Company
AgeTotal Calculated CompensationThis person is connected to 50 board members in 5 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Glenn P. Sblendorio, MBA has been the President at The Medicines Company since February 21, 2012 and has been its Chief Financial Officer since March 17, 2006 and its Treasurer. Mr. Sblendorio serves as Principal Accounting Officer of The Medicines Company and served as its Executive Vice President from March 17, 2006 to February 2012. Mr. Sblendorio served as a Treasurer at Targanta Therapeutics Corp., a subsidiary of Medicines Co. since February 25, 2009. He joined ...

Read Full Background

Corporate Headquarters*

8 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-290-6000
Fax: 973-656-9898

Board Members Memberships*

Director and Chairman of Audit Committee
President, Chief Financial Officer, Treasurer and Director
Director and Chairman of Audit Committee
Director and Member of Audit Committee


Pace University
Fairleigh Dickinson University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$642,593

Stock Options*

Restricted Stock Awards$806,001
All Other Compensation$3,214
Exercisable Options192,907
Exercisable Options Value$1,660,271
Unexercisable Options91,247
Unexercisable Options Value$149,985
Total Value of Options$1,810,255
Total Number of Options284,154

Total Compensation*

Total Annual Cash Compensation$1,055,460
Total Short Term Compensation$642,593
Other Long Term Compensation$809,215
Total Calculated Compensation$2,662,363
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDCO:US $41.00 USD +7.36


Peter J. Arduini Chief Executive Officer, President, Director and Member of Special Award Committee
Integra LifeSciences Holdings Corporation
Dame Pamela Louise Makin MA, Ph.D.(Cantab), MBA, DBEChief Executive Officer and Executive Director
BTG plc
1.1M GBP
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
Erik Bogsch Chief Executive Officer, Managing Director, Member of Executive Board and Director
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
Joze Colaric President of Management Board and Chief Executive Officer
KrKa dd Novo Mesto
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICINES COMPANY, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at